Infection au cours de la cirrhose

Borzio, 2001, Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study, Dig Liver Dis, 33, 41, 10.1016/S1590-8658(01)80134-1 Caly, 1993, A prospective study of bacterial infections in patients with cirrhosis, J Hepatol, 18, 353, 10.1016/S0168-8278(05)80280-6 Grange, 1998, Antibioprophylaxie de l’infection du liquide d’ascite, Gastroenterol Clin Biol, 22, 301 [Consensus conference –– Complications of portal hypertension in adults: consensus text (long and short texts)]. Gastroenterol Clin Biol 2004; 28:135-52. Cadranel, 1999, Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients, J Hepatol, 31, 464, 10.1016/S0168-8278(99)80038-5 Fernandez, 2002, Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis, Hepatology, 35, 140, 10.1053/jhep.2002.30082 Grange, 2004, Nitric oxide and renal function in cirrhotic patients with ascites: from physiopathology to practice, Eur J Gastroenterol Hepatol, 16, 567, 10.1097/00042737-200406000-00009 Wong, 2005, Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club, Gut, 54, 718, 10.1136/gut.2004.038679 Plessier, 2003, Coagulation disorders in patients with cirrhosis and severe sepsis, Liver Int, 23, 440, 10.1111/j.1478-3231.2003.00870.x Bone, 1992, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine, Chest, 101, 1644, 10.1378/chest.101.6.1644 Yuasa, 1997, Clinical study of the application of the concepts of systemic inflammatory response syndrome (SIRS) in liver cirrhosis with or without hepatocellular carcinoma with upper gastrointestinal hemorrhage--a retrospective study., Nippon Shokakibyo Gakkai Zasshi, 94, 643 Such, 2004, Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis, Eur J Gastroenterol Hepatol, 16, 571, 10.1097/00042737-200406000-00010 Guarner, 1999, Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels, Gastroenterology, 117, 414, 10.1053/gast.1999.0029900414 Llach, 1992, Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration, Hepatology, 16, 724, 10.1002/hep.1840160318 Andreu, 1993, Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites, Gastroenterology, 104, 1133, 10.1016/0016-5085(93)90284-J Tito, 1988, Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors, Hepatology, 8, 27, 10.1002/hep.1840080107 Gines, 1990, Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial, Hepatology, 12, 716, 10.1002/hep.1840120416 Silvain, 1993, Prognosis and long-term recurrence of spontaneous bacterial peritonitis in cirrhosis, J Hepatol, 19, 188, 10.1016/S0168-8278(05)80196-5 Rimola, 1985, Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage, Hepatology, 5, 463, 10.1002/hep.1840050320 Bleichner, 1986, Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage, Br J Surg, 73, 724, 10.1002/bjs.1800730916 Soriano, 1992, Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage, Gastroenterology, 103, 1267, 10.1016/0016-5085(92)91514-5 Blaise, 1994, Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage, Hepatology, 20, 34, 10.1002/hep.1840200107 Pauwels, 1996, Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection, Hepatology, 24, 802 Hsieh, 1998, The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding, Am J Gastroenterol, 93, 962, 10.1111/j.1572-0241.1998.00288.x Hoefs, 1985, Spontaneous bacterial peritonitis, Dis Mon, 31, 1, 10.1016/0011-5029(85)90002-1 Grange, 2004, [How to treat and to prevent spontaneous bacterial peritonitis?]., Gastroenterol Clin Biol, 28, B278 Angeloni, 2003, Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis., Am J Gastroenterol, 98, 1844, 10.1111/j.1572-0241.2003.07620.x Runyon, 1988, Optimization of ascitic fluid culture technique, Gastroenterology, 95, 1351, 10.1016/0016-5085(88)90372-1 Terg, 1998, Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages, J Hepatol, 29, 437, 10.1016/S0168-8278(98)80062-7 Ricart, 2000, Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients, J Hepatol, 32, 596, 10.1016/S0168-8278(00)80221-4 Bert, 2003, Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications, Eur J Clin Microbiol Infect Dis, 22, 10, 10.1007/s10096-002-0840-z Grange, 2004, Randomized, comparative study of moxifloxacin versus amoxicillin-clavulanate in the treatment of bacterial infections in cirrhotic patients, Hepatology, 40, 631A Campillo, 2002, Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection, Clin Infect Dis, 35, 1, 10.1086/340617 Vanbiervliet, 2002, Diagnostic accuracy of a rapid urine-screening test (Multistix8SG) in cirrhotic patients with spontaneous bacterial peritonitis, Eur J Gastroenterol Hepatol, 14, 1257, 10.1097/00042737-200211000-00015 Castellote, 2003, Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips, Hepatology, 37, 893, 10.1053/jhep.2003.50120 Nousbaum, 2005, Prospective multicenter study of the prevalence of spontaneous bacterial peritonitis in cirrhotic patients Diagnostic accuracy of urine screening test multistix 8 SG r, J Hepatol, 42, 84, 10.1016/S0168-8278(05)81628-9 Butani, 2004, Rapid diagnosis of infected ascitic fluid using leukocyte esterase dipstick testing, Am J Gastroenterol, 99, 532, 10.1111/j.1572-0241.2004.04084.x Sapey, 2005, Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center, JGastroenterol Hepatol, 20, 187, 10.1111/j.1440-1746.2004.03554.x Jeffries, 1999, Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis., Am J Gastroenterol, 94, 2972, 10.1111/j.1572-0241.1999.01445.x Evans, 2003, Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites, Hepatology, 37, 897, 10.1053/jhep.2003.50119 Runyon, 1990, Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis, Hepatology, 12, 710, 10.1002/hep.1840120415 Pelletier, 1991, Asymptomatic bacterascites: is it spontaneous bacterial peritonitis?, Hepatology, 14, 112, 10.1002/hep.1840140118 Felisart, 1985, Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections, Hepatology, 5, 457, 10.1002/hep.1840050319 Grange, 1990, Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients, Hepatology, 11, 360, 10.1002/hep.1840110305 Rimola, 1995, Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study, Hepatology, 21, 674, 10.1002/hep.1840210312 Navasa, 1996, Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis, Gastroenterology, 111, 1011, 10.1016/S0016-5085(96)70069-0 Sort, 1999, Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis, N Engl J Med, 341, 403, 10.1056/NEJM199908053410603 Terg, 2000, Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study, J Hepatol, 33, 564, 10.1034/j.1600-0641.2000.033004564.x Runyon, 1991, Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis A randomized controlled study of100 patients, Gastroenterology, 100, 1737, 10.1016/0016-5085(91)90677-D Gomez-Jimenez, 1993, Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients, Antimicrob Agents Chemother, 37, 1587, 10.1128/AAC.37.8.1587 Fong, 1989, Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis, Hepatology, 9, 423, 10.1002/hep.1840090313 Campillo, 2001, Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis, Epidemiol Infect, 127, 443, 10.1017/S0950268801006288 Aparicio, 1999, Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences, J Hepatol, 31, 277, 10.1016/S0168-8278(99)80225-6 Llovet, 1997, Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination A retrospective study of 229 spontaneous bacterial peritonitis episodes, J Hepatol, 26, 88, 10.1016/S0168-8278(97)80014-1 Chu, 1995, Prevalence and prognostic significance of bacterascites in cirrhosis with ascites, Dig Dis Sci, 40, 561, 10.1007/BF02064369 Llovet, 2000, Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis, J Hepatol, 33, 423, 10.1016/S0168-8278(00)80278-0 Follo, 1994, Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis, Hepatology, 20, 1495, 10.1002/hep.1840200619 Hampel, 2001, Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis, Am J Gastroenterol, 96, 2206, 10.1111/j.1572-0241.2001.03958.x Amiot, 2002, Re: Hempel etal Risk factors for renal dysfunction in hospitalized cirrhotic patients, Am J Gastroenterol, 97, 1263 Runyon, 1998, Management of adult patients with ascites caused by cirrhosis, Hepatology, 27, 264, 10.1002/hep.510270139 Soriano, 1991, Selective intestinal decontamination prevents spontaneous bacterial peritonitis, Gastroenterology, 100, 477, 10.1016/0016-5085(91)90219-B Singh, 1995, Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial, Ann Intern Med, 122, 595, 10.7326/0003-4819-122-8-199504150-00007 Rolachon, 1995, Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial, Hepatology, 22, 1171 Novella, 1997, Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin, Hepatology, 25, 532, 10.1002/hep.510250306 Grange, 1998, Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial, JHepatol, 29, 430, 10.1016/S0168-8278(98)80061-5 Bernard, 1998, Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis, Digestion, 592, 54, 10.1159/000051423 Younossi, 1997, An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis, JHepatol, 27, 295, 10.1016/S0168-8278(97)80174-2 Inadomi, 1997, Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis, Gastroenterology, 113, 1289, 10.1053/gast.1997.v113.pm9322524 Das, 1998, A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis., Am J Gastroenterol, 93, 1895, 10.1111/j.1572-0241.1998.00545.x Ortiz, 1999, Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients., Hepatology, 29, 1064, 10.1002/hep.510290406 Dupeyron, 1998, Changes in nature and antibiotic resistance of bacteria causing peritonitis in cirrhotic patients over a 20 year period, J Clin Pathol, 51, 614, 10.1136/jcp.51.8.614 Truong, 1995, Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy., J Antimicrob Chemother, 36, 1055, 10.1093/jac/36.6.1055 Cereto, 2003, Role of immunosuppression in the development of quinolone-resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E coli spontaneous bacterial peritonitis, Aliment Pharmacol Ther, 17, 695, 10.1046/j.1365-2036.2003.01491.x Chang, 1998, Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis, Hepatology, 28, 1187, 10.1002/hep.510280504 Pardo, 2000, Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis, Hepatology, 31, 858, 10.1053/he.2000.5746 Garcia-Tsao, 2005, Bacterial infections in cirrhosis: treatment and prophylaxis, J Hepatol, 42, S85, 10.1016/j.jhep.2004.12.006 Watari, 2000, Mortality and prognostic factors in patients with community-acquired pneumonia: an analysis of 231 cases., Nihon Kokyuki Gakkai Zasshi, 38, 509 Foreman, 2003, Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey, Chest, 124, 1016, 10.1378/chest.124.3.1016 Fine, 1990, Prognosis of patients hospitalized with community-acquired pneumonia, Am J Med, 88, 1N Bernstein, 1999, Treatment of community-acquired pneumonia-IDSA guidelines. Infectious Diseases Society of America, Chest, 115, 9S, 10.1378/chest.115.suppl_1.9S Xiol, 1998, Hepatic hydrothorax, Curr Opin Pulm Med, 4, 239, 10.1097/00063198-199807000-00011 Hsu, 2004, Infective endocarditis in patients with liver cirrhosis, J Formos Med Assoc, 103, 355 Danchin, 2005, Prophylaxis of infective endocarditis: French recommendations 2002, Heart, 91, 715, 10.1136/hrt.2003.033183 Barthet, 2004, Antibiotic prophylaxis for digestive endoscopy, Endoscopy, 36, 1123, 10.1055/s-2004-826118 Hirota, 2003, Guidelines for antibiotic prophylaxis for GI endoscopy, Gastrointest Endosc, 58, 475, 10.1067/S0016-5107(03)01883-2 Selby, 1994, Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial, Gastrointest Endosc, 40, 680, 10.1016/S0016-5107(94)70109-1 Schembre, 1991, Post-sclerotherapy bacterial peritonitis, Am J Gastroenterol, 86, 481 Lo, 1994, A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices, Gastrointest Endosc, 40, 675, 10.1016/S0016-5107(94)70108-3 Goulis, 1998, Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage, Hepatology, 27, 1207, 10.1002/hep.510270504 Vivas, 2001, Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding., Dig Dis SciV 46, 2752, 10.1023/A:1012739815892 Benavides, 2003, Further evidence linking bacterial infection and upper G I. bleeding in cirrhosis. Results from a large multicentric prospective survey in Argentina, J Hepatol, 38, 176, 10.1016/S0168-8278(03)80592-5 Rolando, 1993, Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis, J Hepatol, 18, 290, 10.1016/S0168-8278(05)80272-7 Fernandez, 2005, Randomized, multicenter, controlled trial comparing oral norfloxacin versus intravenous ceftriaxone in the prevention of bacterial infection in cirrhotics with severe liver failure and gastrointestinal bleeding, J Hepatol, 42, 4, 10.1016/S0168-8278(05)81417-5 Bernard, 1999, Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis, Hepatology, 29, 1655, 10.1002/hep.510290608 Akriviadis, 1990, Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis, Gastroenterology, 98, 127, 10.1016/0016-5085(90)91300-U Wu, 2001, Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation, J Hepatol, 34, 215, 10.1016/S0168-8278(00)00039-8 Altman, 1995, Survival after a first episode of spontaneous bacterial peritonitis, Prognosis of potential candidates for orthotopic liver transplantation. J Gastroenterol Hepatol, 10, 47 Abraldes, 2003, Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis, Hepatology, 37, 902, 10.1053/jhep.2003.50133